Heidi Kempinski

Company: Aegle Therapeutics

Job title: Chief Operating Officer

Seminars:

Navigating Clinical Trials for Exosome-Based Therapeutics: From Phase I to Approval 10:15 am

• Reviewing the progression of exosome therapeutics from initial trials to market approval • Focusing on patient selection and regulatory navigation to enhance trial design and improve early-stage success rates • Utilizing strategic partnerships to accelerate development timelinesRead more

day: Day Two

Navigating Clinical Trials for Exosome-Based Therapeutics: From Phase I to Approval 9:45 am

• Reviewing the progression of exosome therapeutics from initial trials to market approval • Focusing on patient selection and regulatory navigation to enhance trial design and improve early-stage success rates • Utilizing strategic partnerships to accelerate development timelinesRead more

day: Day Two

Maximizing Exosome & EV Therapeutics Development Efficiency Through Outsourcing & Vendor Capabilities 2:00 pm

Uncover the transformative power of strategic outsourcing in advancing exosome therapeutics development. Explore how outsourcing can streamline processes, accelerate progress, and drive innovation in the field. By leveraging specialized expertise and resources, companies can overcome challenges and maximize opportunities in developing exosome-based therapies. Delving into Funding & Investor Engagement: • Addressing the challenge of maintaining…Read more

day: Pre-Conference Day